Back to Agenda
Session 7: Case Examples of the Impact of Engagement
Session Chair(s)
Stella Stergiopoulos, MPH, MS
Director, Health Economic and Outcomes Research
EQRx, United States
The relationship of patient-centered initiatives to improvements in the drug development process and its outcomes can be difficult to pinpoint due to the complexity of the process and the many factors that also have an impact. Structured approaches to assessing the impact of these initiatives and broad dissemination of the results are key to validating the value of patient-centered practices in drug development. This session will explore case examples of patient-centered interventions that resulted in improved outcomes for stakeholders in the drug product life cycle. Presenters will share their experiences with implementing and evaluating a patient-centered initiative: What outcome objectives did they set? How did these influence plans for the patient-centered intervention? How was success defined and what measures were constructed? How did the implementation experience and results inform future work?
Learning Objective :
Speaker(s)
Speaker
Mary Short, MSN, RN
Eli Lilly and Company, United States
Sr. Research Advisor, Clinical, MDU, Medical Pediatric Capabilities
Speaker
Elizabeth Turcotte, MBA
Bristol-Myers Squibb, United States
Director, Patient Hub
Speaker
Debra Reinhard
Bristol-Myers Squibb, United States
Head, Translational Medicine Enabling Solutions
Speaker
Carrie Corboy, PharmD, RPh
Janssen Global Services, United States
Senior Director, Standards & Execution Excellence
Have an account?